Vestmark Advisory Solutions Inc. Takes Position in Encompass Health Corporation $EHC

Key Points

• Vestmark Advisory Solutions Inc. acquired 4,538 shares of Encompass Health Corporation, valued at approximately $460,000, during the first quarter of 2023.
• Encompass Health reported quarterly earnings of $1.40 per share, beating estimates, and experienced a 12.0% revenue growth year-over-year.
• The company has increased its quarterly dividend from $0.17 to $0.19 per share, with an upcoming payment date on October 15th.

Vestmark Advisory Solutions Inc. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 4,538 shares of the company's stock, valued at approximately $460,000.

A number of other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its position in shares of Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after buying an additional 115 shares during the last quarter. Arlington Trust Co LLC lifted its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after buying an additional 125 shares during the last quarter. IFP Advisors Inc lifted its position in shares of Encompass Health by 5.9% during the 1st quarter. IFP Advisors Inc now owns 2,814 shares of the company's stock valued at $285,000 after buying an additional 158 shares during the last quarter. Merit Financial Group LLC lifted its position in shares of Encompass Health by 4.1% during the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock valued at $427,000 after buying an additional 166 shares during the last quarter. Finally, Sequoia Financial Advisors LLC lifted its holdings in Encompass Health by 6.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after purchasing an additional 172 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

Shares of NYSE:EHC traded down $0.67 on Friday, hitting $122.76. The company's stock had a trading volume of 798,000 shares, compared to its average volume of 895,065. The company has a 50-day simple moving average of $116.38 and a 200 day simple moving average of $110.32. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $124.67. The company has a market capitalization of $12.36 billion, a PE ratio of 24.02, a PEG ratio of 2.15 and a beta of 0.86. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter last year, the firm posted $1.11 EPS. The company's revenue was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Sell-side analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Encompass Health's dividend payout ratio is currently 13.31%.

Analysts Set New Price Targets

EHC has been the topic of a number of recent research reports. UBS Group increased their price objective on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Barclays increased their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. KeyCorp increased their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Finally, Truist Financial increased their price objective on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $134.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.